{"id":18480,"date":"2017-10-12T12:20:01","date_gmt":"2017-10-12T10:20:01","guid":{"rendered":"http:\/\/localhost:8888\/TG180623\/?p=18480"},"modified":"2025-11-17T14:45:20","modified_gmt":"2025-11-17T13:45:20","slug":"sequential-administration-of-mva-based-vaccines-and-pd-1pd-l1-blocking-antibodies-confers-measurable-benefits-on-tumor-growth-and-survival-preclinical-studies-with-mva-%ce%b2gal-and-mva-muc1-tg4010","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/sequential-administration-of-mva-based-vaccines-and-pd-1pd-l1-blocking-antibodies-confers-measurable-benefits-on-tumor-growth-and-survival-preclinical-studies-with-mva-%ce%b2gal-and-mva-muc1-tg4010\/","title":{"rendered":"Sequential administration of MVA-based vaccines and PD-1\/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: preclinical studies with MVA-\u03b2Gal and MVA-MUC1 (TG4010) in a murine tumor model"},"content":{"rendered":"<p><a href=\"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2017.1373921\"><\/a><br \/>\nChristelle Remy-Ziller, et al.<br \/>\nHuman Vaccines &amp; Immunotherapeutics, 2017, 19:0 \u2013 <a href=\"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2017.1373921\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Download the article<\/strong><\/a><br \/>\n<em>Publication<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Christelle Remy-Ziller, et al. Human Vaccines &amp; Immunotherapeutics, 2017, 19:0 \u2013 Download the article Publication<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,130,5,16],"tags":[],"class_list":["post-18480","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-130","category-publication-fr","category-tg4010-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"Lucie Larguier","author_link":"https:\/\/www.transgene.com\/fr\/author\/lcl\/"},"uagb_comment_info":0,"uagb_excerpt":"Christelle Remy-Ziller, et al. Human Vaccines &amp; Immunotherapeutics, 2017, 19:0 \u2013 Download the article Publication","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/18480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=18480"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/18480\/revisions"}],"predecessor-version":[{"id":38884,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/18480\/revisions\/38884"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=18480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=18480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=18480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}